Table 2

 Rates of response over the study period in the phosphatidylcholine (PC) and placebo groups

Treatment groupPC group (n = 30)Placebo group (n = 30)p Value*
CAI, clinical activity index; EAI, endoscopic activity index.
*Fisher’s exact test.
Primary end point analysis
    Clinical remission/improvement (⩾50%)<0.0001
        Yes273
        No327
    Clinical remission (CAI ⩽3)0.00063
        Yes163
        No1427
    ΔCAI (⩾50%)<0.0001
        Decreased273
        Unchanged323
        Increased04
Secondary end point analysis
    ΔEAI (⩾50%)0.00016
        Decreased110
        Unchanged1827
        Increased02
        Not determined11
    ΔHistology score (⩾50%)0.0067
        Decreased133
        Unchanged1119
        Increased11
        Not determined57
    ΔLife quality index (⩾50%)<0.0001
        Increased162
        Unchanged1328
        Decreased00
        Not determined10